Skip to content
INBX Inhibrx Biosciences, Inc. Common Stock
$130.75 1.35% +1.74
Notify me if price changes either direction
Interactive Brokers Logotype

Buy INBX stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 1.9B
Enterprise value 1.9B
Trailing PE 0.19803394
Forward PE -46.258064
PEG Ratio -0.0062441313734694
Enterprise to EBITDA -14.093
Enterprise to revenue 1436.905
Price to book MRQ 235.51096
Price to sales TTM 1450.1664

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2025-12-31
Revenue (TTM) 1.3M
EBITDA -132542000
Diluted EPS TTM -9.04
Total Cash (MRQ) 124.2M
Current ratio (MRQ) 3.93
Operating Cash Flow (TTM) -129794000

INBX trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent INBX News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.